Lannett Company, Inc Obtains FDA Approval To Kick-Start Marketing Of Its Product Phentermine Hydrochloride
Date: 12th December 2007
A latest revelation makes it apparent that the pharmaceutical company, Lannett Company, Inc has successfully obtained approval from the Food and Drugs Administration for the company’s “Supplemental Abbreviated New Drug Application (ANDA)” of its product, 30 mg Phentermine Hydrochloride capsules. After availing the FDA approval, the company now wishes to instantly start the marketing of Phentermine Hydrochloride.
The president and chief executive officer of Lannett Company, Inc, Arthur Bedrosian, states that the approval granted by FDA fairly complements 37.5 mg Phentermine HCI Tablet, a generic product like Adipex-P. He altogether adds that with the help of hard work as well as dedication of the team responsible for continuous research and development, Lannett Company, Inc has been able to seize this approval.
Wolters Kluwer reveals that sales triggered off by generic Phentermine Hydrochloride, the medicine used for the short-term treatment of obesity, has surpassed $37 million during the 12 month period that ended in October 2007.
Source: http://www.drugs.com/ |
